Online application forms for ASPET Travel Awards to EB '10 and ASPET Division Graduate Student Best Abstract Awards, Postdoctoral Scientist Awards, and the Drug Discovery, Development & Regulatory Affairs New Investigator Award are now available online. Read More

Development and Application of PET and SPECT Imaging Ligands as Biomarkers for Drug Discovery and for Pathophysiological Studies of CNS Disorders (R21) (PA 10 023)National Institute of Mental HealthNational Institute on AgingNational Institute on Alcohol Abuse and AlcoholismNational Institute of Read More

  While final FY 2010 spending decisions for NIH have yet to be finalized, attention must turn to FY 2011.    As the President begins deliberations on FY’11 budgets for Federal agencies, it is important that biomedical scientists’ voices be Read More

Loewi's discovery of acetylcholine is a crucial part of the history of pharmacology... Read More

WorldPharma2010 Preliminary Program and Call for Papers is now available.  Read More

This summer Congress passed the “Tobacco Act” that gave FDA expanded powers to regulate tobacco products.  As required by law, FDA has established the Tobacco Products Scientific Advisory Committee (TPSAC) and is requesting nominations for voting and non voting member.  Read More

ASPET Members - Please Support the National Campaign to Educate the Public on the Importance of Animal Models in Medical Research. Read More

Experimental Biology 2010 in Anaheim - It's already time to start making plans for the ASPET's Annual Meeting - the deadline for Abstract Submission is 4 November!   The 2010 meeting will be in Anaheim, California.  I invited Christie Carrico to give us a preview of plans for the meeting and the venue.  It is going to be a great meeting;  I look forward to seeing all of you there.   Brian Cox Read More

Licensing examinations and scientific preparation of future physicians: Views of an ASPET participant Read More

The juxtaposition of two items in the news over the last week or two caught my eye. The Foundation for Biomedical Research (FBR), a non profit foundation supporting the use of animals in biomedical research, announced Read More

 Comparative Effectiveness Research (CER) has been much in the news lately. The American Recovery and Reinvestment Act of 2009 (ARRA) has set aside over $1 billion for the “development and dissemination” of research comparing the effectiveness and outcomes of different health care treatments and strategies (Iglehart, 2009). As part of this effort, the Institute of Medicine was commissioned to recommend national priorities for CER. Their report in June (IOM, 2009) presents a definition of CER, along with a list of 100 priority questions relating to health care delivery that should be addressed quickly, and an outline strategy to facilitate an ongoing and robust CER enterprise. Should pharmacologists be following these developments? Read More